Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
78.55
-0.77 (-0.97%)
Mar 24, 2026, 4:00 PM EDT - Market closed
Dianthus Therapeutics Market Cap
Dianthus Therapeutics has a market cap or net worth of $3.49 billion as of March 24, 2026. Its market cap has increased by 384.90% in one year.
Market Cap
3.49B
Enterprise Value
2.98B
1-Year Change
384.90%
Ranking
Category
Stock Price
$78.55
Market Cap Chart
Since September 12, 2023, Dianthus Therapeutics's market cap has increased from $162.99M to $3.49B, an increase of 2,043.14%. That is a compound annual growth rate of 235.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 4.16B | 135.36% |
| Dec 31, 2025 | 1.77B | 173.85% |
| Dec 31, 2024 | 645.21M | 318.69% |
| Dec 29, 2023 | 154.10M | -5.45% |
| Sep 12, 2023 | 162.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Viking Therapeutics | 3.74B |
| Crinetics Pharmaceuticals | 3.72B |
| Corcept Therapeutics | 3.68B |
| Centessa Pharmaceuticals | 3.64B |
| ACADIA Pharmaceuticals | 3.54B |
| Structure Therapeutics | 3.44B |
| ADMA Biologics | 3.41B |
| NewAmsterdam Pharma Company | 3.33B |